Intravitreal bevacizumab and laser photocoagulation for management of Coats' disease

Poster Details

First Author: O.Karti TURKEY

Co Author(s):    M. Zengin   S. Kerci   T. Kusbeci                       

Abstract Details


To evaluate the effect of supplemental intravitreal bevacizumab and laser photocoagulation for management of Coats' disease.


Case report


Case report


A 14-year-old male patient presented in our department with gradual visual loss in the right eye. Based on the clinical and diagnostic findings Coats' disease was diagnosed. At the initial examination, the best-corrected visual acuity (BCVA) was count fingers at 1 meters in the right eye. The exudative retinal detachment in the right eye was initially treated with intravitreal injections of 2.5 mg bevacizumab. We proceeded with laser photocoagulation of the residual Coats' areas. The subretinal and intraretinal exudates regressed after three weeks. At the last examination the visual acuity was 0.7 in the right eye.


Our study showed that adjuvant therapy with intravitreal anti-VEGF injections in addition to laser photocoagulation in a case of Coats' disease with exudative retinal tissue damage could lead to the stabilization of the retinal findings and to preservation of good visual acuity.

Back to previous
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email:

Privacy policyHotel Terms and Conditions Cancellation policy